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TESTING OF THE PERMEABILITY INCREASING ACTIVITY OF HUMAN
SERUM PREPARATIONS IN THE GUINEA-PIG AND IN MAN*
HALVOR MOLLER, M.D. AND HANS RORSMAN, M.D.
In a series of papers Miles & Wilhelm (1),
Wilhelm, Miles & Mackay (2), and Wilhelm,
Mill & Miles (3) studied enzyme-like globulins
from guinea-pig serum which could reproduce
the vascular phenomena of inflammation. Similar
proteins were also demonstrated in other mam-
mals (4). Wilhelm et al. (2) reported the presence
of a permeability increasing factor in human
serum as well. This was further examined by
Stewart and Bliss (5), Elder and Wilhelm (6),
Mill, Elder, Miles and Wilhelm (7), and by
Möller and Rorsman (8).
By testing different serum preparations with
intracutaneous injections in "blued" guinea-pigs,
Mill et al. (7) found that the most potent perme-
ability increasing factor in human serum con-
sisted mainly of beta-globulins. They also found
that a preparation consisting mainly of alpha-
and beta-globulins, when tested by scratching
into human skin, showed a greater wheal in-
creasing activity than a preparation with
gamma-globulins. Aladjem (9) reported wheal-
and erythema producing effect of fast-moving
gamma- and beta-globulin fractions from human
serum. Möller and Rorsman (8) injected different
serum proteins intracutaneously into human skin
and found the most pronounced permeability
increasing potency in an alpha-globulin prepara-
tion, a slightly smaller effect of a beta-globulin
preparation, and a considerably smaller one in
two preparations consisting of albumin and
gamma-globulins, respectively.
Wilhelm et al. (2) pointed out that if positive
results due to species incompatibility were to be
avoided, sera had to be investigated in the homol-
ogous species. This assumed species incompati-
bility would make experimental work with human
permeability factors technically difficult and it
was therefore considered of interest to compare
the effect of intracutaneously injected human
serum dilutions in man and in guinea-pigs. The
permeability increasing effect of human serum
protein preparations, earlier tested in man by us,
was also studied in guinea-pigs.
* From the Department of Dermatology, IJni-
versity of Lund, Lund, Sweden; (Head: Professor
GOsta Hagerman, M.D.).
Received for publication February 25, 1960.
MATERiAL AND METHODS
Serum di'utions. After slight stasis blood sam-
ples were taken with a syringe from the cubital
vein and were immediately transferred to a glass
tube. The blood was allowed to clot at room tem-
perature for 5—10 minutes, after which the blood
was separated from the walls and centrifuged for
5-10 minutes. Serum was pipetted off and kept for
two hours in +4° C. Thereafter twofold serial
dilutions were prepared with saline from 1/2 to
1/2048; these dilutions were left at room tempera-
ture for 1—2 hours before injection.
Serum proteins. The preparations used were the
commercially available human albumin, alpha-
globulin, beta-globulin and gamma-globulin, pre-
pared by AB KABIt according to Cohn et al. (10,
11). As for the pureness of the preparations, the
"albumin" contained 98 per cent albumin, 1 per
cent alpha2-globulin, and 1 per cent betai-globulin.
The "alpha-globulin" contained about 7 per cent
albumin, about 44 per cent alpha i-globulin, about
40 per cent alpha,-globulin and about 9 per cent
beta1-globulin. The "beta-globulin" contained
about 10 per cent albumin, about 15 per cent
alpha2-globulin and about 75 per cent betai-globu-
un. The "gamma-globulin" contained 5 per cent
albumin, 2 per cent beta1-globulin and 93 per cent
gamma-globulin. All values were determined by
the Tiselius apparatus. All dilutions of the Cohn
separated proteins were prepared with saline and
were then kept at room temperature for one hour.
The stock solution of albumin was 20 per cent and
contained 0.1 mg sodium merthiolate per ml.
Twofold serial dilutions with final concentrations
from 1/200 to 1/800 were prepared. The alpha- and
beta-globulins were supplied as dry substance, and
to 1 mg of the alpha-globulin fraction 1 mg lactose
and 1.2 microg sodium merthiolate had been
added. Twofold serial dilutions, of alpha-globulin
from 1/1600 to 1/102,400, of beta-globulin from
1/200 to 1/6,400, were prepared. The stock solution
of gamma-globulin was 12 per cent and contained
0.1 mg sodium merthiolate per ml. Twofold serial
dilutions with final concentrations from 1/400 to
1/1600 were prepared.
Test Subjects
Man. Patients hospitalized for venereal or skin
diseases not involving the back were chosen. No
t The supply of the protein preparations used in
these experiments, by AB KABI, Stockholm, Swe-
den, is gratefully acknowledged.
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antihistamines or steroids were given for the 24
hours before the tests.
Guinea-pig. Albino guinea-pigs, 350-450 g body
weight were used.
Assay on man. Twofold serial dilutions from
1/32—1/2048 of autologous serum were injected. All
test injections were made on the back about 10
cm laterally to the vertebral column. One ml
syringes and needles of 0.40—0.50 mm diameter
were used and 0.1 ml was injected intracutane..
ously. Immediately after the intracutaneous in-
jections 0.1 ml per kg body weight of 4 per cent
sodium fluorescein in distilled water was injected
intravenously. Within three minutes the tests
were read under Wood's light produced by two
light-sources with maxima at 3650 and 3700 A., re-
spectively. Tests with definite yellow-green flu-
orescence on the whole surface of the wheal pro-
duced by the injection were considered positive.
Tests with saline and tests considered negative
produced no fluorescence or only a slight one lim-
ited to the site of the injection trauma.
Assay on guinea-pig. The method used was es-
sentially that described by Miles and Wilhelm (1).
The skin of the back was depilated, after clipping
away the hair, by a paste consisting of barium sul-
phide 1 part and talcum 2 parts, mixed to a smooth
paste with water immediately before use. For per-
meability tests each animal received 65-75 mg
Pontaininc Sky Blue 6 X (G. P. Gurr) per kg body
weight, given intracardially in a 5 per cent solu-
tion in 0.425 per cent saline. Animals so injected
were used for tests without delay. Intracutaneous
injections were given into the skin of the back 1—3
cm laterally to the vertebral column. The volumes
injected were 0.1 ml and needles of 0.40—0.50 mm
diameter were used. A bright blue area on the in-
jection site, 5 mm or more in diameter was con-
sidered a positive response. As negative control
0.1 ml saline was injected intracutaneously in all
animals and never produced a blue lesion of that
size. Each series of serum dilutions tested in man
was assayed on two guinea-pigs. Twofold serial
dilutions of the serum proteins were tested in ten
animals.
RESULTS
The results of the assays of human serum dilu-
tions, tested in the donor skin and in guinea-pig
skin, are given in table I. There is a good ac-
cordance between the results obtained in man
and guinea-pig.
The results of the assays of human serum pro-
tein tested in ten guinea-pigs are given in table
II. Alpha- and beta-globulins were the most
active preparations, and alpha-globulin some-
what stronger.
TABLE I
The effect of intracutaneously injected autologous
serum from ten human subjects; each. serum was
also tested in two guinea-pigs. The highest
dilution of serum showing a permeability
increase is given
Serum Donor
Test Subjects
Man Guinea-pigs
1
2
3
4
5
6
7
8
9
10
1/256
1/256
1/256
1/256
1/512
1/128
1/128
1/128
1/512
1/256
1/256 1/128
1/256 1/128
1/256 1/128
1/128 1/256
1/512 1/512
1/256 1/128
1/128 1/256
1/256 1/128
1/256 1/256
1/256 1/128
TABLE II
The effect of intracutaneously injected human
serum proteins in ten guinea-pigs. The
highest dilution showing a permeability
increase is given
Guinea-pig Albumin a-globulin -gIobuIin 7-globulin
1 1/200* 1/6400 1/800 1/400*
2 1/200 1/3200 1/3200 1/400
3 1/200* 1/3200 1/400* 1/400*
4 1/200* 1/3200 1/400 1/400*
5 1/200* 1/6400 1/800 1/400
6 1/400 1/25600 1/3200 1/800
7 1/200* 1/1600 1/400* 1/400*
8 1/200 1/3200 1/800 1/400
9 1/200 1/3200 1/800 1/400
10 1/200* 1/3200 1/800 1/800
DISCUSSION
There is good accordance between the results
of testing human serum dilutions in autologous
skin and in the guinea-pig. The permeability
increasing effect of gamma-globulin and of
albumin is stronger in the guinea-pig than in
man, and the effect of alpha- and beta-globulin
is slightly weaker (8). This greater effect of
gamma-globulin and of albumin is probably not
due to their content of a permeability factor,
activable upon dilution, of the kind described by
* No reaction to this dilution. No stronger
concentrations were tested.
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Elder and Wilhelm (6). Other factors may be
involved. Thus, Boake and Lovell (12), Elder and
Wilhelm (6), and Témime, Picard and Témime-
Morhange (13) have observed an inflammatory
effect of undiluted human sera in guinea-pig skin.
The alpha-globulin was more active than the
beta-globulin when tested in guinea-pig skin.
The same relation between the effects of the two
preparations has earlier been observed when
tested in human skin (8). Mill et al. (7) found the
greatest permeability activity of human serum
in a preparation consisting mainly of beta-
globulins. Our protein fractions were not prepared
with a view to obtaining a permeability effect of
the proteins. Transferrin was the main component
in our beta-globulin preparation. The beta-
globulin that forms part of our alpha-globulin
preparation could possibly have a strong perme-
ability activity and be responsible for the stronger
permeability increasing effect of our alpha-
globulin preparation.
SUMMARY
The permeability increasing effect of intra-
cutaneously injected human serum dilutions was
tested in autologous and in guinea-pig skin. The
two methods were equally sensitive and the
results showed a good correlation.
The permeability increasing effect of four
human serum proteins has been tested in guinea-
pig skin. The strongest activity was found in the
alpha- and beta-globulin preparations.
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